See all locations for this study
Phase 2Recruiting

Artesunate Ointment for the Treatment of Anal HSIL in HIV-negative Participants

Sponsored by Frantz Viral Therapeutics, LLC

About this study

This is a phase II double blind, placebo-controlled, randomized study of artesunate ointment for the treatment of HIV-negative men and women who have anal high grade squamous intraepithelial lesions (anal HSIL)

Enrolling at this location

Anal Dysplasia Clinic MidWest

Chicago, Illinois

I'm interested

This study also enrolls at 1 other location. See all.

Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.

Trial data sourced from ClinicalTrials.gov.